Answers are grounded in this paper and cite their sources.
previous stone treatment.Charlson-Comorbidity Index (CCI) and Eastern Cooperative Oncology Group (ECOG) Performance status scores were calculated to assess baseline comorbidity and function. 8,9ata on stone management included duration of follow-up, stone laterality, presence of a solitary functioning kidney, longest length of the index stone as well mean change in stone size, type of staghorn stone, and composition if analyzed.Urine cultures and metabolic workup findings, including a 24-hour urine collection offered to all patients, and the details of their individualized medical therapy were recorded.Primary outcomes were stone-related mortality and progressive renal function deterioration, as defined by a 3.3% or greater yearly decrease in Glomerular renal function (GFR). 10Secondary outcomes were stone-related complications, renal function loss, and allcause mortality.
No takes yet. Share an insight, caveat, or question.
Chakraborty et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: